Meniscus Substitution: The European Perspective on Scaffolds, Allografts, and Prosthetic Implants

Chapter 59


Meniscus Substitution


The European Perspective on Scaffolds, Allografts, and Prosthetic Implants




Treatment of meniscal lesions is the most common surgical intervention performed by orthopedic surgeons today, with more than 1 million surgical interventions involving the meniscus performed annually in the United States and approximately 400,000 in Europe. The meniscus, a semilunar, fibrocartilaginous structure, preserves a pain-free functional knee and plays an important role in the biomechanical functions of the knee, including load bearing, load and force distribution between the femoral condyles and tibial plateau, joint stabilization, lubrication, and proprioception. Over the last few decades, the understanding of meniscal functions and consequently the management of meniscal injuries has continued to evolve, with increasing commitment among physicians to preserve the meniscus whenever possible. The natural history of a meniscus-deficient knee has been shown to involve poor clinical and radiologic outcomes over time, including disruption of load-sharing and shock absorption, diminution of joint stability, and deterioration of articular cartilage with progression to arthrosis. It is now accepted that loss of all or part of the meniscus leads to long-term degenerative changes owing to higher peak stresses on the articular cartilage in the meniscectomized compartment as a result of the decreased contact area. Thus, it seems logical to regenerate or substitute lost meniscus tissue with a scaffold, allograft, or implant to restore the function of the knee joint and to possibly prevent further joint degeneration.


In this chapter, the different options for meniscus substitution are discussed and elaborated. Specific attention is paid to the important differences in indication and surgical technique. Although a number of these therapeutic options have already been proved to be of clinical benefit in multicenter European trials, many of them have not yet been made available outside of Europe—hence the scope of this chapter.



Meniscus Scaffolds for the Treatment of Partial Meniscus Defects


Meniscal regeneration appears to require the physical presence of a scaffold to encourage successful migration and colonization with precursor cells and vessels, eventually leading to the formation of organized meniscal tissue.1,2


In Europe, two scaffolds for the treatment of partial meniscus defects are available. We have acquired extensive experience with a novel, biodegradable, synthetic, acellular scaffold composed of aliphatic polyurethane (Actifit, Orteq, London, United Kingdom), which was designed to fill an unmet clinical need in the treatment of patients with irreparable partial meniscal tissue lesions. The treatment objective of the scaffold is to provide pain relief and restore lost meniscus functionality.


The scaffold comes in two configurations, one for the medial indication and one for the lateral. Design criteria were biocompatibility, strength, flexibility and ease of handling (insertion and suturing with standard arthroscopic techniques), high and interconnected porosity to support tissue ingrowth, and degradation over a suitable time as new tissue forms and matures. The scaffold is highly porous, with approximately 20% of the structure being composed of biodegradable aliphatic polyurethane and the remaining 80% being the pores.


When implanted into the void created in the meniscal tissue after a standard arthroscopic partial meniscectomy and connected to the vascularized portion of the meniscus, the scaffold provides a three-dimensional matrix of interconnected pores for vascular ingrowth.



Indications


Meniscus scaffold implantation represents a novel biologic solution for the treatment of patients with symptomatic partial meniscus defects and limited signs of cartilage degeneration. Because the negative impact of meniscectomy in anterior cruciate ligament (ACL)–injured knees on long-term cartilage degeneration has recently been established, prophylactic meniscus reconstruction with use of a scaffold in the ACL-reconstructed knee with partial meniscectomy could be another indication.


The key inclusion criteria are as follows:



The key exclusion criteria are as follows:




Surgical Technique






Specific Steps


The specific steps of the procedure are outlined in Box 59-1.



Preparation of the damaged meniscus includes surgical debridement and removal of all pathologic tissue and ensuring that the resulting defect site extends into the vascularized red-on-red or red-on-white zone of the damaged portion of the meniscus. Lesions situated farther away from the synovial border are known to have only very limited healing potential and therefore should be excluded from this type of meniscoplasty. For enhancement of healing, the meniscal rim may be punctured to create vascular access channels. Gentle rasping of the synovial lining may further stimulate meniscal healing (Fig. 59-1). The meniscal defect should be measured along the curvature of its inner edge using the accompanying specially designed meniscal ruler and meniscal ruler guide. Actifit is then measured and with a scalpel is cut to fit in such a place and manner as to ensure that sterility is maintained at all times. To allow for shrinkage caused by suturing of the spongelike material and to ensure a snug optimal fit into the prepared defect, oversizing of the length by 10% is advised (3 mm for defects smaller than 3 cm and 5 mm for defects 3 cm or larger). To achieve a perfect fit of the scaffold with the native meniscus at the anterior junction, the anterior side should be cut at an oblique angle of 30 to 45 degrees (Fig. 59-2). Although the Actifit material is strong and flexible, the device should be handled with care and manipulated with a blunt-nosed grasper, such as the Acufex Grasper Tissue Tensioner (Smith & Nephew). Marking the cranial and caudal meniscal scaffold surface with a sterile marking pen avoids positioning problems. The Actifit device should be clamped at the posterior part of the scaffold and placed into the knee joint through the anteromedial or anterolateral portal. To ensure a good initial position of the meniscal scaffold and facilitate further fixation, the surgeon may place a vertical holding suture in the native meniscus tissue to bring Actifit through the eye of this holding suture.




Fixation of Actifit is achieved by suturing the scaffold to the native meniscus tissue. All standard meniscus suturing techniques may be used; the suturing technique employed depends on the location of the defect and the surgeon’s experience and preference. All-inside suturing has proven effective, and this technique is commonly used for the posterior horn and posterior part of the rim. For the middle and anterior part of the rim, all-inside, inside-out, and outside-in techniques may be used. Horizontal sutures with an outside-in technique are commonly used for the anterior horn and posterior horn.


The manufacturer recommends standard commercially available size 2.0 nonresorbable sutures, such as polyester or polypropylene and braided or monofilament sutures.


Fixation of the device should begin with a horizontal all-inside suture from the posterior edge of the scaffold to the native meniscus. Suturing should be secure; however, attention must be paid not to overtighten sutures, because this may alter and indent the surface of the scaffold. In line with well-known meniscal suturing techniques, the distances between the sutures should be kept to approximately 0.5 cm. Each suture should be placed at one third to one half of the scaffold’s height, as determined from the lower surface of the scaffold.


After suturing, if required, the scaffold may be further trimmed and fine-tuned intra-articularly with a basket punch. Once the scaffold has been securely fixed, stability of the fixation is tested by use of the probe and movement of the knee through a range of motion (0 to 90 degrees).


To enhance the healing response, bone marrow aspiration can be performed from the notch area and directly applied on the dry scaffold after implantation. Figure 59-3 depicts a scaffold 1 year after implantation showing full peripheral integration to the meniscus rim.


Stay updated, free articles. Join our Telegram channel

Sep 11, 2016 | Posted by in SPORT MEDICINE | Comments Off on Meniscus Substitution: The European Perspective on Scaffolds, Allografts, and Prosthetic Implants

Full access? Get Clinical Tree

Get Clinical Tree app for offline access